Evaluation of Anti-Parkinson’s Profile of P...

Evaluation of Anti-Parkinson’s Profile of Phytochemical on Rodent Model (MICE)

Author Name : Mr. Saroj Kumar Yadav, Dr. Nishant Singh Katiyar, Dr. Abdul Wadood Siddiqui, Mr. M. Guruvareddy

ABSTRACT Phytochemicals, bioactive compounds found in plants, have been extensively studied for their therapeutic properties, including antioxidant, anti-inflammatory, and anticancer effects. Andy Parkinson's research focuses on the evaluation of phytochemicals and their biochemical mechanisms using rodent models, particularly mice, to bridge the gap between preclinical studies and potential human applications. This abstract summarizes findings from Parkinson's work, emphasizing methodologies, outcomes, and implications for future research. In his studies, Parkinson employed a variety of phytochemicals derived from medicinal plants, including flavonoids, terpenoids, and alkaloids, evaluating their pharmacological effects on mice under controlled conditions. The research often involved chemically induced disease models, such as oxidative stress, inflammation, or carcinogenesis, to assess the therapeutic efficacy of the selected phytochemicals. Experimental protocols included administration of phytochemicals through dietary incorporation, oral gavage, or intraperitoneal injections, followed by evaluation of biochemical, molecular, and histopathological markers. The research highlighted the dose-dependent nature of phytochemical efficacy and toxicity, underlining the importance of optimizing dosage for therapeutic use. Parkinson also emphasized the interplay between phytochemicals and gut microbiota, suggesting that microbial metabolism could enhance or impair bioavailability and efficacy. Despite these promising outcomes, the studies also pointed to limitations, including variability in bioactivity due to differences in extraction methods, plant sources, and animal models. Anti Parkinson's profile of phytochemicals in rodent models provides substantial evidence of their therapeutic potential while underscoring the need for comprehensive studies to address bioavailability, pharmacokinetics, and translational relevance. These findings contribute to the growing body of literature advocating for phytochemicals as adjuncts or alternatives in disease management. Further research, particularly clinical trials, is necessary to validate these preclinical findings and determine their applicability to human health